https://www.worldpharmatoday.com/research-insight/afatinib-bibw-2992-triples-progression-free-survival-in-phase-iii-study-in-lung-cancer-patients/ Magazine for the C-level Pharma Executives Sun, 10 Oct 2010 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4